Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Jerome J. Dorlack is President and CEO at Adient. OQRO lists 13 transactions filed with the SEC under this name, the latest on Nov 17, 2026, each linked to the official Form 4.
President and CEO
Disclosures on record
13
Companies involved
1
AdientADNT
13 disclosures · Aug 2025 – Nov 2026 · 1 sold
Nov 12, 2026427Kdisclosed Nov 17
DetailsOfficial recordNov 16, 20263,612disclosed Nov 17
DetailsOfficial recordNov 13, 202631Kdisclosed Nov 17
DetailsOfficial recordNov 14, 202628Kdisclosed Nov 17
DetailsOfficial recordFeb 8, 20265,896disclosed Feb 10
DetailsOfficial recordJan 1, 202615Kdisclosed Jan 5
DetailsOfficial recordJan 1, 20265,234disclosed Jan 5
DetailsOfficial recordNov 17, 20253,081disclosed Nov 18
DetailsOfficial recordNov 13, 2025213Kdisclosed Nov 17
DetailsOfficial recordNov 13, 20257,559disclosed Nov 17
DetailsOfficial recordNov 14, 202528Kdisclosed Nov 17
DetailsOfficial recordNov 16, 20253,506disclosed Nov 17
DetailsOfficial recordAug 7, 2025Sold~$273Kdisclosed Aug 8
DetailsOfficial recordJerome J. Dorlack bought shares on the open market in 2020, and has not bought since 2020. Sales in 4 of the 7 years since 2020.
Jerome J. Dorlack reported 1 open-market purchase and 6 sales since 2020; purchases in 2020.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $273K1×1 trade |
| 2023 | — | $633K1×1 trade |
| 2022 | — | $406K2×2 trades |
| 2021 | — | $576K2×2 trades |
| 2020 | $35K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Jerome J. Dorlack reported 1 open-market purchase and 6 sales here, 2020 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Jerome J. Dorlack reported holding 994,794 shares of Adient (ADNT), worth about $15.4M at the last close of $15 (Nov 18, 2026).
Adient's proxy statement reports total compensation of $13.1M for Jerome J. Dorlack for fiscal year 2025, after $9.49M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Jan 21, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Adient ADNT | 994,794 | 995K direct | $15 | $15.4M | Nov 16, 2026 |
Is this Jerome J. Dorlack’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 16, 2026, Jerome J. Dorlack reported holding 994,794 shares of Adient (ADNT). At the last close of $15 on Nov 18, 2026, that is about $15.4M. This is the stake disclosed in filings, not a net worth.
No public filing gives Jerome J. Dorlack's net worth. What SEC Form 4 shows is the stock stake: 994,794 shares of Adient (ADNT), about $15.4M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Adient's proxy statement reports total compensation of $13.1M for Jerome J. Dorlack for fiscal year 2025, after $9.49M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Jerome J. Dorlack bought shares on the open market in 2020, and has not bought since 2020. Sales in 4 of the 7 years since 2020.
In SEC filings since 2020: the latest open-market purchase is from 2020; the latest open-market sale is from 2025.
Adient (ADNT), from 2020 to 2025: 1 purchase and 6 sales.